I would say this year and next are so different from last year. There has been extreme volatility and Sigma has improved position markedly and API has not. My view only.
Pfizer, pharmacy alliance, floods for API, sale of Aspen all have happened since last annual report.
Add to My Watchlist
What is My Watchlist?